Clinical Trial Update: Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of lenvatinib in pediatric/adolescent and young adult patients with refractory or relapsed solid malignancies and osteosarcoma has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer
• Osteosarcoma

Drugs mentioned

• Lenvatinib (lenvatinib)

Snippet

Sponsor: Eisai Limited | Conditions: Tumors, Solid Malignant Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-09-17